A Phase I/II Randomized Double-Blind Placebo-Controlled Trial of Cannabidiol for chronic radiculopathic pain syndromes maintained on chronic opioid therapy

Brief description of study

The purpose of this research study is to see how safe and effective Cannabidiol (CBD) is for the treatment of chronic non-cancer spinal radiculopathic pain conditions in people maintained on an ongoing dose of opioid pain medications. The researchers will assess the effects of CBD on opioid medication use, pain as well as aspects of thinking, emotions and behavior.

Clinical Study Identifier: s21-00230

ClinicalTrials.gov Identifier: NCT04760613

Principal Investigator: Stephen Ross.

Other Investigators: Lisa V. Doan, Yian Zhang, Yongzhao Shao, Jing Wang, Esther Blessing.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies